University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
NCT Number: NCT00948207
The investigators will test whether narrative life review and web-based social networking for middle aged adults with advanced cancer will improve:
1. existential well being (and reduce psychological distress) 2. generativity and relationship quality, thereby mediating the intervention effects
The investigators will also conduct exploratory process analyses of each participant's social network.
Looking for future studies?
Notify Me30 year–60 year
All sexes
Interventional
Not applicable
Madison, Wisconsin, 53792, United States
Middle aged patients with advanced cancer report more distress, and active search for meaning and personal growth than older and/or early stage patients. Nonetheless, such positive growth is far from typical and interventions help. Expert-guided life review reduced distress for hospice patients, but is not widely accessible-and many patients lack the energy or skill to write their own life story. Online cancer information and support expert systems improve quality of life. Patients are increasingly developing their own social networks, but many lack the skills to do so. Moreover the effects on social networking on patient well-being have not been studied.
"My Living Story" elicits a dignity-enhancing life story via a telephone interview (based on Chochinov, JAMA 2002), and delivers the edited transcript on the patient's personal miLivingStory social network. miLivingStory links to a life review education website (called miStory) with links to high quality cancer information, support and interactive planning tools.
We hypothesize that telling, revising and sharing the life story with one's selected social network will improve the patient's existential well-being and reduce their distress. Furthermore, we hypothesize that these effects will be mediated by My Living Story's effects on improving the patient's sense of legacy (generativity) and the quality of their relationships. Our exploratory observational analyses of each individual miLivingStory network will contribute to an understanding of how social network configuration and communication patterns correlate with measured outcomes
We will recruit and randomize 100 patients with advanced cancer. The control group will receive a personalized web portal (called miOwnResources) with links to high quality cancer information, social support and interactive planning tools, and a feature to add their own links. All participants will sign informed consent forms, complete a pre-test survey and post-tests at tow and four months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Components include:
miOwnResources is a personalized, password-protected web portal to high quality websites that provide cancer information, cancer research databases for "do your own research," social support, and interactive planning tools. miOwnResources also has a page for participants to add their own weblinks.
Time frame: 0, 2 and 4 months
Time frame: 0, 2, and 4 months
University of Wisconsin, Madison
Other
Online Narrative Interventions and Family Support for Advanced Cancer Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05990920
Advanced Cancer, Advanced Solid Tumor
Los Angeles, California, United States
View Trial DetailsNCT03941262
Advanced Cancer, Advanced Solid Tumor
Santa Monica, California, United States
View Trial DetailsNCT05364905
Advanced Cancer, Disease Attributes
Argenteuil, France
View Trial DetailsNCT00741403
Advanced Cancer, Advanced Malignancies
Peoria, Arizona, United States
View Trial Details